Novel Piperine Derivatives with Antidiabetic Effect as PPAR-γ Agonists

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Piperine, an alkaloid from Piper nigrum L., is known for its pungency.
• Developing novel antidiabetic agents with improved efficacy and safety is a critical medical need.

Purpose of the Study:

• To synthesize novel piperine derivatives incorporating a benzothiazole moiety.
• To evaluate the antidiabetic potential and mechanism of action of these synthesized compounds.

Main Methods:

• Piperine was isolated and hydrolyzed to piperic acid.
• Twenty piperine-benzothiazole derivatives were synthesized.
• Antidiabetic activity was assessed using the oral glucose tolerance test and a streptozotocin-induced diabetic model.
• Mechanism of action was explored via PPAR-γ agonism assays.
• In vivo studies evaluated effects on body weight, lipid peroxidation, and hepatotoxicity.

Main Results:

• Nine out of twenty novel piperine analogues demonstrated significant antidiabetic activity.
• The most active compounds (5b, 6a-h) exhibited superior efficacy compared to the standard drug, rosiglitazone.
• These active derivatives were confirmed as PPAR-γ agonists.
• Further studies indicated favorable effects on body weight and reduced hepatotoxicity.

Conclusions:

• Novel piperine-benzothiazole derivatives possess potent antidiabetic properties.
• The mechanism involves PPAR-γ agonism.
• These compounds represent promising lead molecules for developing new antidiabetic therapies with potentially fewer side effects.